Bevacizumab in Patients With Severe Covid-19

Clinical trial NCT04305106 · UNKNOWN

Trial details

NCT number: NCT04305106
Sponsor: Qilu Hospital of Shandong University
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

COVID-19 Pneumonia

Start date: 2023-01-12
Primary completion: 2023-11-30
Enrollment: 588

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.